[Arguments in favor of postsynaptic antagonism by captopril (SQ 14,225) in the perfused kidney]. 1982

D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran

The potential antagonistic effect of high doses of Captopril on renal vascular response to exogenous administration or nerve stimulated release of norepinephrine (NE) was assessed in isolated blood-free perfused rat and rabbit kidneys respectively. At the doses of 0,09 mM and 0,45 mM in rat kidney, captopril blunted significantly the vasoconstrictor effect of exogenous NE (20, 40 and 100 ng) whilst responses to angiotensin II (2,5 and 10 ng) were slightly reduced at the highest dose and responses to serotonin (20, 40 and 100 mg) remained unaffected by either doses of Captopril. The other effective converting enzyme inhibitor, SQ 20881 had no effect on pressor responses to norepinephrine at similar doses. In preliminary rabbit studies, a likewise blunting of pressor effect of exogenous norepinephrine was obtained at the doses of captopril of 0,23 mM and 0,45 mM. Furthermore, these doses of captopril had no effect on either basal or nerve-stimulated NE release whilst nerve-stimulated vasoconstriction was significantly and reversibly blunted at both doses. These studies suggest a) that the inhibitory effect of Captopril on NE renal vasoconstriction in not primarily dependent on converting enzyme inhibition; b) that the observed alpha-antagonistic activity of high doses of captopril occurs principally at a post-junctional level.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran
January 1988, Archives internationales de pharmacodynamie et de therapie,
D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran
December 1979, European journal of pharmacology,
D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran
January 1985, Indian journal of dermatology, venereology and leprology,
D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran
February 1981, Postgraduate medical journal,
D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran
February 1983, Clinical nephrology,
D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran
August 1979, European journal of pharmacology,
D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran
March 1982, Experientia,
D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran
August 1979, Japanese journal of pharmacology,
D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran
January 1981, Hypertension (Dallas, Tex. : 1979),
D Casellas, and C Chevillard, and B Jover, and M Dupont, and A Mimran
February 1981, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!